AI Verdict
HOOK has stronger fundamentals based on our AI analysis.
HOTH vs HOOK Fundamental Comparison
| Metric | HOTH | HOOK |
|---|---|---|
| Revenue | $1.2B | $2.0M |
| Net Income | $-12.5M | $-15.4M |
| Net Margin | -1.0% | -769.8% |
| ROE | -202.7% | -45.3% |
| ROA | -164.0% | -25.2% |
| Current Ratio | 4.72x | 3.61x |
| Debt/Equity | 0.00x | 0.03x |
| EPS | $-0.90 | $-1.23 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HOTH vs HOOK: Frequently Asked Questions
Is HOTH or HOOK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HOOK has stronger fundamentals. HOTH is rated STRONG SELL (88% confidence) while HOOK is rated SELL (45% confidence). This is not investment advice.
How does HOTH compare to HOOK fundamentally?
Hoth Therapeutics, Inc. has ROE of -202.7% vs HOOKIPA Pharma Inc.'s -45.3%. Net margins are -1.0% vs -769.8% respectively.
Which stock pays higher dividends, HOTH or HOOK?
HOTH has a dividend yield of N/A or no dividend while HOOK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HOTH or HOOK for long term?
For long-term investing, consider that HOTH has STRONG SELL rating with 88% confidence, while HOOK has SELL rating with 45% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HOTH vs HOOK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HOTH vs HOOK, the AI consensus favors HOOK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.